Bill · H.R. 5571· House(119-HR-5571)
Expanding Seniors’ Access to PFAS Testing Act
- Introduced
- 9/26/2025
- Last activity
- 9/26/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Debbie Dingell
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
This bill, titled the "Expanding Seniors' Access to PFAS Testing Act," aims to amend the Social Security Act. It specifically seeks to provide no-cost coverage for PFAS testing under the Medicare program. The legislation defines PFAS testing as a blood test ordered by a physician to determine the concentration of perfluoroalkyl and polyfluoroalkyl substances. This change would apply to testing performed on or after January 1, 2028.
Yes· 3 of 5
Would people over 65 be better off under this?+7
The bill provides seniors on Medicare with no-cost coverage for PFAS blood testing starting in 2028.
Would retired people be better off under this?+7
The bill eliminates cost-sharing for PFAS testing for those covered under the Medicare program.
Does this make health care easier to get in general?+6
The bill makes blood testing for PFAS concentration more accessible by removing cost-sharing for Medicare beneficiaries.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
No-cost coverage for testing: Under Section 2(b), Medicare would pay 100 percent of the lesser of the actual charges or the determined fee schedule for PFAS testing performed on or after January 1, 2028. This provides a financial benefit to individuals by removing cost-sharing for these specific blood tests.
-
Access to specific diagnostic information: Section 2(a) defines "PFAS testing" as a blood test ordered by a physician to determine the concentration of perfluoroalkyl and polyfluoroalkyl substances. This allows Medicare beneficiaries to have these specific concentrations determined through a physician-ordered test.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text of the bill provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+7Good For Seniors+7Good For Low Income Households+4
- Healthcare
- Improves Healthcare Access+6Increases Medicare Funding+5
- 11/21/2025
- 1 Cosponsor added.
- 9/26/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
Brian FitzpatrickRepublican · Pennsylvania
Kristen McDonald RivetDemocrat · Michigan